Keystone Financial Group Acquires 19,838 Shares of Abbott Laboratories (NYSE:ABT)
4 Articles
4 Articles
Abbott Laboratories (ABT): Exploring a 7.56% Potential Upside in the Healthcare Giant
Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare industry, continues to capture investor interest with its robust market presence and promising growth metrics. This U.S.-based medical devices giant boasts a market capitalization of $220.05 billion, underscoring its formidable position in the sector. As of the latest trading data, Abbott’s stock is priced at $126.88, reflecting a minor price change of 0.02%. ### Valuation and Growth …
Keystone Financial Group Acquires 19,838 Shares of Abbott Laboratories (NYSE:ABT)
Keystone Financial Group grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 118.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,634 shares of the healthcare product maker’s stock after acquiring an additional 19,838 shares during the period. Keystone […]
Bragg Financial Advisors Inc Decreases Holdings in Abbott Laboratories (NYSE:ABT)
Bragg Financial Advisors Inc lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 113,074 shares of the healthcare product maker’s stock after selling 1,895 shares during the period. Bragg Financial Advisors […]
Abbott Laboratories (NYSE:ABT) Shares Purchased by Keystone Financial Group
Keystone Financial Group boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 118.1% in the fourth quarter, Holdings Channel reports. The fund owned 36,634 shares of the healthcare product maker’s stock after purchasing an additional 19,838 shares during the period. Keystone Financial Group’s holdings in Abbott Laboratories were worth $4,497,000 as of its most recent filing with the Securities and Exchange Commission. S…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage